Isomerase is a fully integrated synthetic biology partner focused on microbial strain engineering and development for high-level production of proteins, enzymes and other biomolecules. With over a decade of experience, we offer proprietary genetic tools, a curated culture collection of metabolically diverse strains, and optimised expression chassis suited to industrial deployment. Our proprietary ML-enabled enzyme engineering platform designs and prioritises variants with improved performance characteristics, tailored to demanding process conditions. End-to-end, Isomerase supports upstream and downstream process development, delivering robust, scalable workflows and seamless technology transfer to CDMO partners to help partners progress from early concept to commercial readiness.